Reconstructed human epidermis‐based testing strategy of skin sensitization potential and potency classification using epidermal sensitization assay and in silico data
Open Access
- 17 October 2023
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 44 (3) , 415-427
Abstract
The hazards and potency of skin sensitizers are traditionally determined using animal tests such as the local lymph node assay (LLNA); however, significant progress has been made in the development of non‐animal test methods addressing the first three mechanistic key events of adverse outcome pathway in skin sensitization. We developed the epidermal sensitization assay (EpiSensA), which is a reconstructed human epidermis‐based assay, by measuring four genes related to critical keratinocyte responses during skin sensitization. Four in vitro skin sensitization test methods (EpiSensA, direct peptide reactivity assay [DPRA], KeratinoSens™, and human cell line activation test [h‐CLAT]) were systematically evaluated using 136 chemicals including lipophilic chemicals and pre/pro‐haptens, which may be related to assay‐specific limitations. The constructed database included existing and newly generated data. The EpiSensA showed a broader applicability domain and predicted the hazards with 82.4% and 78.8% accuracy than LLNA and human data. The EpiSensA could detect 76 out of 88 sensitizers at lower concentrations than the LLNA, indicating that the EpiSensA has higher sensitivity for the detection of minor sensitizing constituents. These results confirmed the potential use of the EpiSensA in evaluating a mixture of unknown compositions that can be evaluated by animal tests. To combine different information sources, the reconstructed human epidermis‐based testing strategy (RTS) was developed based on weighted multiple information from the EpiSensA and TImes MEtabolism Simulator platform for predicting Skin Sensitization (TIMES‐SS; RTSv1) or Organization for Economic Cooperation and Development (OECD) QSAR Toolbox automated workflow (RTSv2). The predictivities of the hazards and Globally Harmonized System (GHS) subcategories were equal to or better than the defined approaches (2 out of 3, integrated testing strategy [ITS]v1, and ITSv2) adopted as OECD Guideline 497.Keywords
This publication has 30 references indexed in Scilit:
- Glutathione synthesisBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Putting the parts together: Combining in vitro methods to test for skin sensitizing potentialsRegulatory Toxicology and Pharmacology, 2012
- Dual neuroprotective pathways of a pro‐electrophilic compound via HSF‐1‐activated heat‐shock proteins and Nrf2‐activated phase 2 antioxidant response enzymesJournal of Neurochemistry, 2011
- Involvement of P2X7 purinergic receptor and MEK1/2 in interleukin-8 up-regulation by LL-37 in human gingival fibroblastsJournal of Periodontal Research, 2011
- Gene expression profiling defines the role of ATP-exposed keratinocytes in skin inflammationJournal of Dermatological Science, 2010
- ATF3, a Hub of the Cellular Adaptive-Response Network, in the Pathogenesis of Diseases: Is Modulation of Inflammation a Unifying Component?Gene Expression, 2010
- Skin Sensitizers Induce Antioxidant Response Element Dependent Genes: Application to the In Vitro Testing of the Sensitization Potential of ChemicalsToxicological Sciences, 2007
- Haptens, prohaptens and prehaptens, or electrophiles and proelectrophilesContact Dermatitis, 2006
- Predictive identification of human skin sensitization thresholdsContact Dermatitis, 2005
- Characterization of Multiple P2X Receptors in Cultured Normal Human Epidermal KeratinocytesJournal of Investigative Dermatology, 2005